Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 2Phase 2 2

Status

Unknown 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1Gynecologic 1

Conditions

Peritoneal Neoplasms 1Hepatocellular Carcinoma Resectable 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 28Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × lobaplatin × Gastrointestinal × Clear all
NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Zhujiang Hospital

Phase 3 Unknown
90 enrolled
Gastrointestinal

Hepatocellular Carcinoma Resectable

NCT03221608 2017-07-18

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
300 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01034683 2010-01-05

Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Taian Cancer Hospital

Phase 3 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡